Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.800
+0.030 (1.69%)
At close: Nov 22, 2024, 4:00 PM
1.840
+0.040 (2.22%)
After-hours: Nov 22, 2024, 7:58 PM EST
PACB Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for PACB stock have an average target of 2.92, with a low estimate of 2.00 and a high estimate of 6.00. The average target predicts an increase of 62.22% from the current stock price of 1.80.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PACB stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Hold | 7 | 7 | 7 | 7 | 7 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 15 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
UBS | UBS | Strong Buy → Hold Downgrades $2 | Strong Buy → Hold | Downgrades | $2 | +11.11% | Nov 11, 2024 |
Scotiabank | Scotiabank | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +233.33% | Nov 11, 2024 |
Piper Sandler | Piper Sandler | Hold Maintains $2 → $2.5 | Hold | Maintains | $2 → $2.5 | +38.89% | Nov 11, 2024 |
Scotiabank | Scotiabank | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +288.89% | Aug 28, 2024 |
Stephens & Co. | Stephens & Co. | Buy Maintains $3.5 → $2.5 | Buy | Maintains | $3.5 → $2.5 | +38.89% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
168.65M
from 200.52M
Decreased by -15.89%
Revenue Next Year
212.30M
from 168.65M
Increased by 25.88%
EPS This Year
-1.30
from -1.21
EPS Next Year
-0.69
from -1.30
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 179.0M | 238.4M | 347.6M | ||
Avg | 168.7M | 212.3M | 272.5M | ||
Low | 152.0M | 177.1M | 194.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -10.7% | 41.3% | 63.7% | ||
Avg | -15.9% | 25.9% | 28.4% | ||
Low | -24.2% | 5.0% | -8.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.89 | -0.50 | -0.29 | ||
Avg | -1.30 | -0.69 | -0.53 | ||
Low | -1.48 | -0.89 | -0.67 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.